Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1400 of 2228 entries
View as:

Tolerability and Potential ECG Effects After a Single Oral Dose of Pentoxyverine Citrate in Healthy Male and Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02183649 Org: User:
Start: 11/30/09 End: - Due: -

Safety and Pharmacokinetics of Single Rising Oral Doses of BI 224436 ZW in Healthy Male Volunteers.

Phase: N/A Priority: Normal
NCT ID: NCT02183662 Org: User:
Start: 11/30/09 End: - Due: -

Efficacy and Safety of Actilyse 2 mg/ 2 ml in Comparison to Saline Solution in Patients With Central Venous Access Device Occlusion

Phase: N/A Priority: Normal
NCT ID: NCT01958164 Org: User:
Start: 09/30/13 End: 04/30/14 Due: 04/30/15

Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Airways Disease

Phase: N/A Priority: Normal
NCT ID: NCT02231372 Org: User:
Start: 03/31/04 End: - Due: -

Study to Assess the Bioequivalence of Two Batches of Tamsulosin Hydrochloride in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02266511 Org: User:
Start: 08/31/99 End: - Due: -

Japan Long-term Safety for Tiotropium Plus Olodaterol

Phase: N/A Priority: Normal
NCT ID: NCT01536262 Org: User:
Start: 02/29/12 End: 09/30/13 Due: 09/30/14

Safety and Tolerability of Pharmaton Capsules in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02181959 Org: User:
Start: 12/31/98 End: - Due: -

Lendormin D® Tablet (Drug Use Result Survey)

Phase: N/A Priority: Normal
NCT ID: NCT02224014 Org: User:
Start: 06/30/05 End: - Due: -

BI 1356 (Linagliptin) in Combination With Metformin and a Sulphonylurea in Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00602472 Org: User:
Start: 02/29/08 End: - Due: -

Phase I Dose Escalation Study of Concomitant BIBF 1120 and BIBW 2992 in Patients With Advanced Solid Tumours.

Phase: N/A Priority: Normal
NCT ID: NCT00998296 Org: User:
Start: 10/31/09 End: 07/31/14 Due: 07/31/15

Pharmacokinetic of Tadalafil Co-administered With Tipranavir/Ritonavir to Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02253862 Org: User:
Start: 12/31/05 End: - Due: -

A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study)

Phase: N/A Priority: Normal
NCT ID: NCT00168857 Org: User:
Start: 07/09/03 End: - Due: -

Evaluation the Effectiveness of the Risk Minimisation Activities in the Treatment of Stroke Prevention in Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT02433366 Org: User:
Start: 01/31/15 End: 08/31/15 Due: 08/31/16

Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Airways Disease

Phase: N/A Priority: Normal
NCT ID: NCT02231359 Org: User:
Start: 01/31/04 End: - Due: -

Nintedanib and Weekly Docetaxel in Lung Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02668393 Org: User:
Start: 03/07/16 End: 11/27/19 Due: 11/27/20

IPF Italian Observational Study (FIBRONET) in Idiopathic Pulmonary Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT02803580 Org: User:
Start: 11/17/15 End: 05/15/18 Due: 05/15/19

A Study to Test How Well Healthy Men Tolerate Different Doses of BI 706321

Phase: N/A Priority: Normal
NCT ID: NCT03971695 Org: User:
Start: 06/18/19 End: 12/04/20 Due: 12/04/21

Safety, Tolerability and Efficacy of Switching From Talipexole to Pramipexole in Patients With Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02231905 Org: User:
Start: 01/31/04 End: - Due: -

Chart Review Study to Describe the Clinical Profile of Idiopathic Pulmonary Fibrosis (IPF) Patients Treated With Nintedanib (OFEV®) in Real-world Practice in Spain

Phase: N/A Priority: Normal
NCT ID: NCT03281200 Org: User:
Start: 10/24/17 End: 06/07/18 Due: 06/07/19

Pharmacokinetic Properties of Nevirapine Extended Release Tablets When Administered Orally in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02194218 Org: User:
Start: 09/30/09 End: - Due: -

This Study Tests How Healthy Men Tolerate Different Doses of BI1015550. The Study Also Tests How BI 1015550 is Taken up by the Body

Phase: N/A Priority: Normal
NCT ID: NCT03230487 Org: User:
Start: 08/10/17 End: 01/16/18 Due: 01/16/19

Relative Bioavailability of Multiple Oral Doses of BI 187004 and Metformin After Co-administration Compared to Multiple Oral Doses of BI 187004 Alone and Metformin Alone in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02109679 Org: User:
Start: 05/31/14 End: 07/31/14 Due: 07/31/15

Single Rising Dose Study of BI 135585 XX in Health Asian Male Volunteers.

Phase: N/A Priority: Normal
NCT ID: NCT01291732 Org: User:
Start: 02/28/11 End: - Due: -

Metabolism and Pharmacokinetics of [14C]-BIBF 1120 in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02182154 Org: User:
Start: 10/31/05 End: - Due: -

Efficacy and Safety of Lacidipine in Chronic Stable Angina

Phase: N/A Priority: Normal
NCT ID: NCT02232607 Org: User:
Start: 04/30/98 End: - Due: -